Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction
Authors:
- 5 August 2014
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 45 (4) , 1769-1777
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 31 references indexed in Scilit:
- Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung CancerCancer Research and Treatment, 2013
- Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cellsMolecular Cancer, 2012
- Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung CancerThe Korean Journal of Internal Medicine, 2010
- Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase ExpressionTuberculosis and Respiratory Diseases, 2009
- Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosisLeukemia, 2007
- Statins and cancer preventionNature Reviews Cancer, 2005
- Apoptosis in cancer—implications for therapySeminars in Oncology, 2004
- Inhibition of human tumor cell growthin vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228International Journal of Cancer, 2001
- The Temporal Relationship between Protein Phosphatase, Mitochondrial CytochromecRelease, and Caspase Activation in ApoptosisExperimental Cell Research, 1999
- Regulation of the mevalonate pathwayNature, 1990